Literature DB >> 19618088

Variable clinical phenotypes of alpha-thalassemia syndromes.

Sylvia Titi Singer1.   

Abstract

Genetic mutations of the alpha genes are common worldwide. In Asia and particularly Southeast Asia, they can result in clinically significant types of alpha-thalassemia, namely hemoglobin (Hb) H disease and Hb Bart's hydrops fetalis. The latter is generally a fatal intrauterine condition, while Hb H disease results in clinical complications that are frequently overlooked. The high prevalence of the carrier state and the burden of these diseases (and other alpha-thalassemia variants) call for more attention for improved screening methods and better care.

Entities:  

Mesh:

Year:  2009        PMID: 19618088      PMCID: PMC5823233          DOI: 10.1100/tsw.2009.69

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  13 in total

1.  Coinheritance of Gaucher disease and α-thalassemia resulting in confusion between two inherited hematologic diseases.

Authors:  Ebrahim Miri-Moghaddam; Arash Velayati; Majid Naderi; Nahid Tayebi; Ellen Sidransky
Journal:  Blood Cells Mol Dis       Date:  2010-09-16       Impact factor: 3.039

2.  Impact of Genotype of Beta Globin Gene on Hepatic and Myocardial Iron Content in Egyptian Patients with Beta Thalassemia.

Authors:  Tamer H Hassan; Mohamed M Abdel Salam; Marwa Zakaria; Mohamed Shehab; Dina T Sarhan; El Sayed H Zidan; Khaled M El Gerby
Journal:  Indian J Hematol Blood Transfus       Date:  2018-11-08       Impact factor: 0.900

3.  Molecular and Haematological Characteristics of alpha-Thalassemia Deletions in Yogyakarta Special Region, Indonesia.

Authors:  Nailil Husna; Niken Satuti Nur Handayani
Journal:  Rep Biochem Mol Biol       Date:  2021-10

Review 4.  Differences in the clinical and genotypic presentation of sickle cell disease around the world.

Authors:  Santosh L Saraf; Robert E Molokie; Mehdi Nouraie; Craig A Sable; Lori Luchtman-Jones; Gregory J Ensing; Andrew D Campbell; Sohail R Rana; Xiao M Niu; Roberto F Machado; Mark T Gladwin; Victor R Gordeuk
Journal:  Paediatr Respir Rev       Date:  2013-11-15       Impact factor: 2.726

Review 5.  Genetic epidemiology, hematological and clinical features of hemoglobinopathies in Iran.

Authors:  Zohreh Rahimi
Journal:  Biomed Res Int       Date:  2013-06-18       Impact factor: 3.411

6.  Comparative plasma protein profiling of hemoglobin H disease.

Authors:  Kamonlak Leecharoenkiat; Wannapa Sornjai; Kornpat Khungwanmaythawee; Atchara Paemanee; Chartchai Chaichana; Sittiruk Roytrakul; Suthat Fucharoen; Saovaros Svasti; Duncan R Smith
Journal:  Dis Markers       Date:  2014-06-15       Impact factor: 3.434

7.  Evaluation of Alpha-Thalassemia Mutations in Cases with Hypochromic Microcytic Anemia: The İstanbul Perspective.

Authors:  Zeynep Karakaş; Begüm Koç; Sonay Temurhan; Tuğba Elgün; Serap Karaman; Gamze Asker; Genco Gençay; Çetin Timur; Zeynep Yıldız Yıldırmak; Tiraje Celkan; Ömer Devecioğlu; Filiz Aydın
Journal:  Turk J Haematol       Date:  2015-08-06       Impact factor: 1.831

Review 8.  Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes.

Authors:  Christina N Kontoghiorghe; George J Kontoghiorghes
Journal:  Drug Des Devel Ther       Date:  2016-01-29       Impact factor: 4.162

9.  Hematologic features of alpha thalassemia carriers.

Authors:  Haleh Akhavan-Niaki; Reza Youssefi Kamangari; Ali Banihashemi; Vahid Kholghi Oskooei; Mandana Azizi; Ahmad Tamaddoni; Sadegh Sedaghat; Mohsen Vakili; Hassan Mahmoudi Nesheli; Soraya Shabani
Journal:  Int J Mol Cell Med       Date:  2012

10.  Association between serum ferritin level, cardiac and hepatic T2-star MRI in patients with major β-thalassemia.

Authors:  A Eghbali; H Taherahmadi; M Shahbazi; B Bagheri; L Ebrahimi
Journal:  Iran J Ped Hematol Oncol       Date:  2014-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.